-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
At this stage, it is clinically recommended that women undergo breast cancer screening at the age of 40 to reduce breast cancer mortality
Most breast cancers are invasive (81%), and more than 90% are invasive ductal carcinoma (IDC) and/or invasive lobular carcinoma (ILC
Recently, a study published in the European Journal of Radiology explored the qualitative and quantitative characteristics of breast lesions found by mammography examination and DBT, and further evaluated the diagnostic value of the two methods in predicting the nature of benign and malignant lesions, which provided a reference for
This study reviewed patients who underwent digital breast tombosynthetic techniques for further examination from 2017 to 2020 for mammography screening for breast lesions, and the lesions were biopsied
This performance eventually included 28 patients with invasive ductal carcinoma or invasive lobular cancer and 40 patients with
This study shows that the volume doubling time of mammography screening lesions is an important indicator
Original source:
Negar Sadeghipour,Joseph Tseng,Kristen Anderson,et al.